Legend Biotech Corp ADR (NASDAQ: LEGN) is -30.81% lower on its value in year-to-date trading and has touched a low of $36.92 and a high of $70.13 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LEGN stock was last observed hovering at around $41.54 in the last trading session, with the day’s gains setting it 0.09%.
Currently trading at $41.63, the stock is 1.66% and -4.88% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.6 million and changing 0.22% at the moment leaves the stock -16.47% off its SMA200. LEGN registered -32.22% loss for a year compared to 6-month loss of -8.59%. The firm has a 50-day simple moving average (SMA 50) of $43.9197 and a 200-day simple moving average (SMA200) of $49.961025.
The stock witnessed a 1.66% gain in the last 1 month and extending the period to 3 months gives it a -16.41%, and is -3.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.29% over the week and 4.74% over the month.
Legend Biotech Corp ADR (LEGN) has around 1826 employees, a market worth around $7.64B and $520.18M in sales. Profit margin for the company is -66.92%. Distance from 52-week low is 12.76% and -40.64% from its 52-week high. The company has generated returns on investments over the last 12 months (-23.87%).
The EPS is expected to grow by 43.95% this year.
Legend Biotech Corp ADR (LEGN) Top Institutional Holders
The shares outstanding are 183.45M, and float is at 181.93M with Short Float at 12.59%.
The top institutional shareholder in the company is FMR LLC with over 17.62 million shares valued at $780.46 million. The investor’s holdings represent 9.6819% of the LEGN Shares outstanding. As of 2024-06-30, the second largest holder is PRICE T ROWE ASSOCIATES INC /MD/ with 11.49 million shares valued at $508.86 million to account for 6.3126 of the shares outstanding. The other top investors are RA CAPITAL MANAGEMENT, L.P. which holds 7.51 million shares representing 4.1246% and valued at over $332.48 million, while HHLR ADVISORS, LTD. holds 3.6463 of the shares totaling 6.64 million with a market value of $293.93 million.
Legend Biotech Corp ADR (LEGN) Insider Activity
#####
Still, SEC filings show that on Sep 20 ’24, Macomber Lori (Officer) Proposed Sale 90,060 shares at an average price of $48.91 for $4.41 million. The insider now directly holds shares of Legend Biotech Corp ADR (LEGN).
